Verification Opinion of Zhongtai Securities Co., Ltd. on the Change of Partial Fundraising Purpose of Shaoxing Beisimei Chemical Co., Ltd.
Zhongtai Securities Co., Ltd. (hereinafter referred to as "Zhongtai Securities" or "the Sponsor") is the sponsor during the continuous supervision phase of Shaoxing Beisimei Chemical Co., Ltd. (hereinafter referred to as "the Company" or "the Listed Company") for its initial public offering and listing on the Growth Enterprise Market. According to relevant regulations including the "Administrative Measures for the Sponsorship of Securities Issuance and Listing," "Shenzhen Stock Exchange Growth Enterprise Market Listing Rules," "Regulations on the Supervision of Fundraising by Listed Companies," and "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange - Standardized Operations of Growth Enterprise Market Companies," Zhongtai Securities has conducted a prudent verification of the change in the use of part of the fundraising for the acquisition of equity and related transactions. The verification results are as follows:
I. Overview of the Change in the Use of Initial Fundraising
(1) Basic Situation of Fundraising from the Initial Public Offering in 2019
Shaoxing Beisimei Chemical Co., Ltd. (hereinafter referred to as "Beisimei" or "the Company") was approved by the China Securities Regulatory Commission with document number [2019] 1783. On November 2019, it publicly issued 30.3 million shares of RMB ordinary shares (A shares) at an issue price of RMB 14.25 per share, with a total fundraising amount of RMB 431.775 million. After deducting issuance expenses of RMB 38.7974 million, the actual net fundraising amount was RMB 392.9776 million. The funds were received in November 2019, verified by the verification report No. [2019] 7999 from Rongcheng Accounting Firm. The Company has managed the fundraising through a special account.
(2) Use and Management of Initial Fundraising
As of December 31, 2025, the investment projects and usage of the funds raised from the initial public offering are as follows:
| No. | Project Name | Total Investment Amount | Amount to be Invested from Fundraising | Cumulative Investment Amount from Fundraising |
|---|---|---|---|---|
| 1 | Hydrogen Series, Dimethylpentyl Series, Methomyl Series Product Technological Transformation Project | 30,000.00 | 26,297.76 | 8,009.11 |
| 2 | Annual Production of 6,000 Tons Dimethylpentyl Technological Transformation Project | 10,000.00 | 6,800.00 | - |
| 3 | Annual Production of 5,000 Tons High Purity Pseudo-boehmite Project Phase I - 20,000 Tons/Year Special Alcohol Series Green New Materials Project | 133,741.59 | 11,488.65 | 12,094.92 |
| 4 | New Enterprise R&D Center Technological Transformation Project | 10,660.92 | 10,000.00 | - |
| 5 | Permanent Supplement of Working Capital | - | 10,094.37 | 10,094.37 |
| 6 | Marketing Network Expansion Project | 10,000.00 | 3,000.00 | - |
| 7 | Acquisition of 80% Equity of Ningbo Jielike | 34,800.00 | 3,111.95 | 3,111.95 |